EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Medium‐term pulmonary outcomes (

Simge Atar Bese iD, Adnan Mercan iD, Zeynep Gülec Koksal iD, Soner Sertan Kara iD, Güneş Ozcolpan iD, Pinar Uysal iD, Duygu Erge iD

Pediatric Allergy and Immunology · 2026-05 · 37 (5)

DOI: 10.1111/pai.70347 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pediatric Allergy and Immunology, online erschienen am 05.05.2026. Verfasst von Simge Atar Bese und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatric Allergy and Immunology, Afyonkarahisar Health Sciences University School of Medicine, Afyonkarahisar, Turkey. Hauptthemen laut MEDLINE: COVID-19, SARS-CoV-2, Lung. Die Arbeit nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

Although coronavirus disease 2019 (COVID‐19) usually exhibits a mild clinical course in children, concerns remain regarding persistent airway dysfunction after recovery. This study aimed to evaluate pulmonary function tests (PFTs) in children following mild COVID‐19 infection and to compare the findings with those of healthy controls.

Methods

In this prospective cross‐sectional study, children aged 6–18 years with polymerase chain reaction–confirmed COVID‐19 infection were identified retrospectively from February 2022 and evaluated prospectively between June and December 2022. Fifty‐eight post‐COVID‐19 patients and 56 age‐ and sex‐matched healthy controls were included, and their demographic and clinical characteristics were recorded. PFTs were assessed using impulse oscillometry (IOS) followed by spirometry.

Results

There were no significant differences in demographic and anthropometric measurements between the post‐COVID‐19 group and the healthy controls. In terms of IOS measurements, zR5 and R5‐20 (reflecting airway resistance) were higher and zX5 and zX20 (reflecting airway reactance) were lower in the post‐COVID‐19 group ( p = .006, p = .002, p < .001, and p = .001, respectively). No significant differences were observed in spirometric parameters, including zFEV1, zFVC, zFEV1/FVC, and zFEF25–75. Notably, three patients exhibited persistent cough and dyspnea after COVID‐19, had FEV1 values

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19SARS-CoV-2LungHumansChildSpirometryOscillometryFemaleAdolescentMaleCross-Sectional StudiesProspective StudiesRespiratory Function TestsPost-Acute COVID-19 SyndromeAirway Resistance

Stichwörter der Autor:innen

Covid‐19SARS‐COV2impulse oscillometrypediatricspulmonary function testspirometry

Autor:innen und Institutionen

  • Department of Pediatric Allergy and Immunology, Afyonkarahisar Health Sciences University School of Medicine, Afyonkarahisar, Turkey.
  • Department of Pediatric Allergy and Immunology, Osmaniye State Hospital, Osmaniye, Turkey.
  • Department of Pediatric Allergy and Immunology, Etlik City Hospital, Ankara, Turkey.
  • Department of Pediatric Infectious Diseases, Aydın Adnan Menderes University School of Medicine, Aydın, Turkey.
  • Department of Microbiology, Aydın Adnan Menderes University School of Medicine, Aydın, Turkey.
  • Department of Pediatric Allergy and Immunology, Aydın Adnan Menderes University School of Medicine, Aydın, Turkey.

ORCID-Profile: Simge Atar Bese, Adnan Mercan, Zeynep Gülec Koksal, Soner Sertan Kara, Güneş Ozcolpan, Pinar Uysal, Duygu Erge

Zitieren

APA

Atar Bese, S., Mercan, A., Koksal, Z. G., Kara, S. S., Ozcolpan, G., Uysal, P., & Erge, D. (2026). Medium‐term pulmonary outcomes (. Pediatric Allergy and Immunology, 37(5). https://doi.org/10.1111/pai.70347

Vancouver

Atar Bese S, Mercan A, Koksal ZG, Kara SS, Ozcolpan G, Uysal P, et al. Medium‐term pulmonary outcomes (. Pediatric Allergy and Immunology. 2026;37(5). doi:10.1111/pai.70347

BibTeX
@article{AtarBese2026,
  author = {Atar Bese, Simge and Mercan, Adnan and Koksal, Zeynep Gülec and Kara, Soner Sertan and Ozcolpan, Güneş and Uysal, Pinar and Erge, Duygu},
  title = {Medium‐term pulmonary outcomes (},
  journal = {Pediatric Allergy and Immunology},
  year = {2026},
  volume = {37},
  number = {5},
  doi = {10.1111/pai.70347}
}
Kostenlos starten →